Track topics on Twitter Track topics that are important to you
Radiodermatitis, also commonly referred to as radiation dermatitis in medical terminology, is a symptom caused as result of using radiation therapy used to treat cancer as well as exposure to radiation during nuclear disasters. While treating cancer with radiotherapy, cumulative daily doses of radiation are given to the treatment field or target site on the body prevent normal skin to repopulate and weakens the skin integrity at and around the radiation field. Degree of radiodermatitis may be acute or chronic and encompasses localized erythema, skin shedding desquamation, hair loss epilation, fibrosis, necrosis, and other similar conditions. According to the WHO, the number of new patients of cancer is expected to grow by 70% in the next two decades. The growing number of cancer patients around the world is the chief driving force behind the global radiodermititis market's growth however higher cost and adequate infrastructure in the major parts of the world is expected to be key restraining factor for the global radiodermititis market.
Geographically AsiaPacific dominated radiodermititis market driven by best in the developing healthcare infrastructure, increasing awareness, increasing cancer patients and growing spending by the citizens towards healthcare expenditure. AsiaPacific was followed by Europe and North America as second and third largest market for radiodermititis market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.
This report identifies the global radiodermititis market size in for the year 20142016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global radiodermititis market.
This report segments global radiodermititis market on the basis of product type, distribution channel type and regional market as follows:
Radiodermititis Market, By Product Type: Topical, Oral Medication, Dressings and others
Radiodermititis Market, By Distribution channel: Hospital Pharmacy, Retail Pharmacy Store, Online Store and others
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, AsiaPacific APAC, and Rest of the World RoW covering all the major country level markets in each of the region
This report identifies all the major companies operating in the radiodermititis market. Some of the major companies' profiles in detail are as follows:
3M Health Care
Molnlycke Health Care
Smith Nephew plc
Derma Sciences, Inc.
Original Article: Radiodermititis Market: By Product type Topical, Oral Medication and Dressings, By Distribution Channel Hospital Pharmacy, Retail Pharmacy Store, and Online Store By RegionForecast 20162021 [Updated: 19082016] Prices from USD $5250NEXT ARTICLE
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...